Citations (110)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Moein Khormali, Sama Heidari, Sana Ahmadi, Melika Arab Bafrani, Vali Baigi & Mahdi Sharif-Alhoseini. (2022) N-methyl-D-aspartate receptor antagonists in improving cognitive deficits following traumatic brain injury: a systematic review. Brain Injury 36:9, pages 1071-1088.
Read now
Read now
A FitzGerald, L Main, U Duff, J Foggo, F Rowney, N Haire & R McLean. (2021) Does amantadine maintain function in long-established brain injury? A single case experimental design. Brain Injury 35:11, pages 1443-1450.
Read now
Read now
Yu Gao, Linlin Ma, Fang Liang, Yi Zhang, Lin Yang, Xuehua Liu & Jing Yang. (2020) The use of amantadine in patients with unresponsive wakefulness syndrome after severe cerebral hemorrhage. Brain Injury 34:8, pages 1084-1088.
Read now
Read now
Heather M. Ma & Ross D. Zafonte. (2020) Amantadine and memantine: a comprehensive review for acquired brain injury. Brain Injury 34:3, pages 299-315.
Read now
Read now
B.J. Ter Mors, A.P.M. Backx, P. Spauwen, R.W.H.M. Ponds, P.N. Van Harten & C.M. Van Heugten. (2019) Efficacy of amantadine on behavioural problems due to acquired brain injury: A systematic review. Brain Injury 33:9, pages 1137-1150.
Read now
Read now
Sonya Kim, Marianne Mortera, Xiaolei Hu, Shilpa Krishnan, Lilian Hoffecker, Amy Herrold, Lauren Terhorst, Laurie King, Joseph Machtinger, Jennifer M. Zumsteg, Ahmed Negm & Patricia Heyn. (2019) Overview of pharmacological interventions after traumatic brain injuries: impact on selected outcomes. Brain Injury 33:4, pages 442-455.
Read now
Read now
Hossein Ghalaenovi, Arash Fattahi, Jalil Koohpayehzadeh, Mahmoud Khodadost, Neda Fatahi, Morteza Taheri, Alireza Azimi, Sadra Rohani & Hessam Rahatlou. (2018) The effects of amantadine on traumatic brain injury outcome: a double-blind, randomized, controlled, clinical trial. Brain Injury 32:8, pages 1050-1055.
Read now
Read now
Swati Mehta, Amanda McIntyre, Shannon Janzen, Jerome Iruthayarajah, Ali Bateman & Robert Teasell. (2018) Pharmacological management of agitation among individuals with moderate to severe acquired brain injury: A systematic review. Brain Injury 32:3, pages 287-296.
Read now
Read now
Shree Uddhav Bhalerao, Carly Geurtjens, Garry Robert Thomas, Christopher Ross Kitamura, Carrol Zhou & Michelle Marlborough. (2013) Understanding the neuropsychiatric consequences associated with significant traumatic brain injury. Brain Injury 27:7-8, pages 767-774.
Read now
Read now
Matthew J. Meyer, Joseph Megyesi, Jay Meythaler, Manuel Murie-Fernandez, Jo-Anne Aubut, Norine Foley, Katherine Salter, Mark Bayley, Shawn Marshall & Robert Teasell. (2010) Acute management of acquired brain injury Part III: An evidence-based review of interventions used to promote arousal from coma. Brain Injury 24:5, pages 722-729.
Read now
Read now
Sharon E. Williams. (2007) Amantadine treatment following traumatic brain injury in children. Brain Injury 21:9, pages 885-889.
Read now
Read now
Olga N. Kokiko & Robert J. Hamm. (2007) A review of pharmacological treatments used in experimental models of traumatic brain injury. Brain Injury 21:3, pages 259-274.
Read now
Read now
Laura Rees, Shawn Marshall, Cheryl Hartridge, David Mackie & Margaret Weiser$suffix/text()$suffix/text(). (2007) Cognitive interventions post acquired brain injury. Brain Injury 21:2, pages 161-200.
Read now
Read now
Shari Hughes, Angela Colantonio, P. Lina Santaguida & Thomas Paton. (2005) Amantadine to enhance readiness for rehabilitation following severe traumatic brain injury. Brain Injury 19:14, pages 1197-1206.
Read now
Read now
C. T. Kim, H. Kim, B. Wechsler & S. W. Kim. (2005) Pneumatosis intestinalis (PI) following severe traumatic brain injury. Brain Injury 19:12, pages 1059-1061.
Read now
Read now
Articles from other publishers (95)
Guilherme Santos Piedade, Bernardo Assumpcao de Monaco, James D. Guest & Joacir Graciolli Cordeiro. (2023) Review of spinal cord stimulation for disorders of consciousness. Current Opinion in Neurology 36:6, pages 507-515.
Crossref
Crossref
Julia M. Carlson & David J. Lin. (2023) Prognostication in Prolonged and Chronic Disorders of Consciousness. Seminars in Neurology 43:05, pages 744-757.
Crossref
Crossref
Soo Jeong Han, Gahee Park & Jee Hyun Suh. (2022) Transcranial direct current stimulation combined with amantadine in repetitive mild traumatic brain injury in rats. BMC Neuroscience 23:1.
Crossref
Crossref
Matthew I. Hiskens. (2022) Targets of Neuroprotection and Review of Pharmacological Interventions in Traumatic Brain Injury. Journal of Pharmacology and Experimental Therapeutics 382:2, pages 149-166.
Crossref
Crossref
Sumie Kakehi & Danielle M. Tompkins. (2021) Reply: A Review of Pharmacologic Neurostimulant Use During Rehabilitation and Recovery after Brain Injury. Annals of Pharmacotherapy 56:7, pages 861-862.
Crossref
Crossref
Clare Bajamundi-Plyler, Rachael Hatfield, James Tyler Rosier & Durga Roy. (2022) A Case Study on the Management of the Behavioral Sequelae of Traumatic Brain Injury. Journal of the Academy of Consultation-Liaison Psychiatry 63:4, pages 316-323.
Crossref
Crossref
Zubair Ahmed. (2022) Current Clinical Trials in Traumatic Brain Injury. Brain Sciences 12:5, pages 527.
Crossref
Crossref
Olivier Rascol, Margherita Fabbri & Werner Poewe. (2021) Amantadine in the treatment of Parkinson's disease and other movement disorders. The Lancet Neurology 20:12, pages 1048-1056.
Crossref
Crossref
Sumie Kakehi & Danielle M. Tompkins. (2021) A Review of Pharmacologic Neurostimulant Use During Rehabilitation and Recovery After Brain Injury. Annals of Pharmacotherapy 55:10, pages 1254-1266.
Crossref
Crossref
Elham Rahmani, Tricia M. Lemelle, Ehsan Samarbafzadeh & Anita S. Kablinger. (2021) Pharmacological Treatment of Agitation and/or Aggression in Patients With Traumatic Brain Injury: A Systematic Review of Reviews. Journal of Head Trauma Rehabilitation 36:4, pages E262-E283.
Crossref
Crossref
Wojciech Danysz, Andrzej Dekundy, Astrid Scheschonka & Peter Riederer. (2021) Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials. Journal of Neural Transmission 128:2, pages 127-169.
Crossref
Crossref
Davi Jorge Fontoura Solla & Wellingson Silva Paiva. 2021. Traumatic Brain Injury. Traumatic Brain Injury
179
185
.
Shoumitro Deb, Lina Aimola, Verity Leeson, Mayur Bodani, Lucia Li, Tim Weaver, David Sharp, Paul Bassett & Mike Crawford. (2020) Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial. BMJ Open 10:9, pages e036300.
Crossref
Crossref
David J. Gagnon, Angela M. Leclerc, Richard R. Riker, Caitlin S. Brown, Teresa May, Kristina Nocella, Jennifer Cote, Ashley Eldridge & David B. Seder. (2020) Amantadine and Modafinil as Neurostimulants During Post-stroke Care: A Systematic Review. Neurocritical Care 33:1, pages 283-297.
Crossref
Crossref
Andrea Loggini, Ruth Tangonan, Faten El Ammar, Ali Mansour, Fernando D. Goldenberg, Christopher L. Kramer & Christos Lazaridis. (2020) The role of amantadine in cognitive recovery early after traumatic brain injury: A systematic review. Clinical Neurology and Neurosurgery 194, pages 105815.
Crossref
Crossref
Jessica Traeger, Brian Hoffman, Jennifer Misencik, Alan Hoffer & Jason Makii. (2020) Pharmacologic Treatment of Neurobehavioral Sequelae Following Traumatic Brain Injury. Critical Care Nursing Quarterly 43:2, pages 172-190.
Crossref
Crossref
G.R. Ramazanov, E.A. Kovaleva, E.V. Shevchenko & L.Kh-B. Akhmatkhanova. (2020) The use of amantadine sulfate in ischemic stroke. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 120:12, pages 56.
Crossref
Crossref
Yu Gao, Yi Zhang, Zhuo Li, Linlin Ma & Jing Yang. (2020) Persistent vegetative state after severe cerebral hemorrhage treated with amantadine. Medicine 99:33, pages e21822.
Crossref
Crossref
Matt Roth & Drew Nowakowski. 2020. Concussion Management for Primary Care. Concussion Management for Primary Care
101
110
.
Michelle Eventov. (2019) Amantadine minimally improves arousal in patients with severe traumatic brain injury. Clinical Research In Practice: The Journal of Team Hippocrates 5:2.
Crossref
Crossref
Jun Yup Kim, Hyun Jung Kim, Hyo Seon Choi, So Young Park & Deog Young Kim. (2019) Effects of Cerebrolysin® in Patients With Minimally Conscious State After Stroke: An Observational Retrospective Clinical Study. Frontiers in Neurology 10.
Crossref
Crossref
David Williamson, Anne Julie Frenette, Lisa D Burry, Marc Perreault, Emmanuel Charbonney, Francois Lamontagne, Marie-Julie Potvin, Jean-Francois Giguère, Sangeeta Mehta & Francis Bernard. (2019) Pharmacological interventions for agitated behaviours in patients with traumatic brain injury: a systematic review. BMJ Open 9:7, pages e029604.
Crossref
Crossref
Ginger Polich, Mary Alexis Iaccarino & Ross Zafonte. 2019. Psychopharmacology of Neurologic Disease. Psychopharmacology of Neurologic Disease
253
267
.
David L. Ripley, Sangeeta Driver, Ryan Stork & Mithra Maneyapanda. 2019. Rehabilitation After Traumatic Brain Injury. Rehabilitation After Traumatic Brain Injury
133
163
.
Flora M. HammondMark ShererJames F. MalecRoss D. ZafonteSureyya DikmenJennifer BognerKathleen R. BellJason BarberNancy Temkin. (2018) Amantadine Did Not Positively Impact Cognition in Chronic Traumatic Brain Injury: A Multi-Site, Randomized, Controlled Trial. Journal of Neurotrauma 35:19, pages 2298-2305.
Crossref
Crossref
Prajakta Ghate, Ashok Bhanage, Hrishikesh Sarkar & Anand Katkar. (2022) Efficacy of amantadine in improving cognitive dysfunction in adults with severe traumatic brain injury in Indian population: A pilot study. Asian Journal of Neurosurgery 13:03, pages 647-650.
Crossref
Crossref
Justin R. Davanzo & Shelly D. Timmons. 2018. Controversies in Severe Traumatic Brain Injury Management. Controversies in Severe Traumatic Brain Injury Management
179
190
.
Mary Pat Murphy. 2018. Encyclopedia of Clinical Neuropsychology. Encyclopedia of Clinical Neuropsychology
3377
3378
.
Jawaher A. GramishBrian J. KoppAsad E. Patanwala. (2017) Effect of Amantadine on Agitation in Critically Ill Patients With Traumatic Brain Injury. Clinical Neuropharmacology 40:5, pages 212-216.
Crossref
Crossref
Paul Carrillo-MoraJuan Manuel Alcantar-ShrammKievka M. Almaguer-BenavidesJulio José Macías-GallardoAlim Fuentes-BelloMarlene A. Rodríguez-Barragán. (2017) Pharmacological Stimulation of Neuronal Plasticity in Acquired Brain Injury. Clinical Neuropharmacology 40:3, pages 131-139.
Crossref
Crossref
Mary Pat Murphy. 2017. Encyclopedia of Clinical Neuropsychology. Encyclopedia of Clinical Neuropsychology
1
2
.
Sicong Tu & Jian Tu. 2017. Neurological Regeneration. Neurological Regeneration
13
48
.
Peter O. Jenkins, Mitul A. Mehta & David J. Sharp. (2016) Catecholamines and cognition after traumatic brain injury. Brain 139:9, pages 2345-2371.
Crossref
Crossref
D. Plantier & J. Luauté. (2016) Drugs for behavior disorders after traumatic brain injury: Systematic review and expert consensus leading to French recommendations for good practice. Annals of Physical and Rehabilitation Medicine 59:1, pages 42-57.
Crossref
Crossref
Musa Basseer Sami & Rafey Faruqui. (2015) The effectiveness of dopamine agonists for treatment of neuropsychiatric symptoms post brain injury and stroke. Acta Neuropsychiatrica 27:6, pages 317-326.
Crossref
Crossref
Dominic Dougall, Norman Poole & Niruj Agrawal. (2015) Pharmacotherapy for chronic cognitive impairment in traumatic brain injury. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Sean C. Rose, Kevin D. Weber, James B. Collen & Geoffrey L. Heyer. (2015) The Diagnosis and Management of Concussion in Children and Adolescents. Pediatric Neurology 53:2, pages 108-118.
Crossref
Crossref
Flora M. Hammond, Ryan S. Barrett, Timothy Shea, Ronald T. Seel, Thomas W. McAlister, Darryl Kaelin, David K. Ryser, John D. Corrigan, Nora Cullen & Susan D. Horn. (2015) Psychotropic Medication Use During Inpatient Rehabilitation for Traumatic Brain Injury. Archives of Physical Medicine and Rehabilitation 96:8, pages S256-S273.e14.
Crossref
Crossref
Stephanie Stelmaschuk, Mary Colleen Will & Tamara Meyers. (2015) Amantadine to Treat Cognitive Dysfunction in Moderate to Severe Traumatic Brain Injury. Journal of Trauma Nursing 22:4, pages 194-203.
Crossref
Crossref
A. Estraneo, A. Pascarella, P. Moretta, V. Loreto & L. Trojano. (2015) Clinical and electroencephalographic on–off effect of amantadine in chronic non-traumatic minimally conscious state. Journal of Neurology 262:6, pages 1584-1586.
Crossref
Crossref
Scott D. Spritzer, Carolyn L. Kinney, John Condie, Kay E. Wellik, Charlene R. Hoffman-Snyder, Dean M. Wingerchuk & Bart M. Demaerschalk. (2015) Amantadine for Patients With Severe Traumatic Brain Injury. The Neurologist 19:2, pages 61-64.
Crossref
Crossref
Mary Alexis Iaccarino, Saurabha Bhatnagar & Ross Zafonte. 2015. Traumatic Brain Injury, Part I. Traumatic Brain Injury, Part I
411
422
.
Flora M. Hammond, Allison K. Bickett, James H. Norton & Rashmi Pershad. (2014) Effectiveness of Amantadine Hydrochloride in the Reduction of Chronic Traumatic Brain Injury Irritability and Aggression. Journal of Head Trauma Rehabilitation 29:5, pages 391-399.
Crossref
Crossref
Jennie Ponsford, Mark Bayley, Catherine Wiseman-Hakes, Leanne Togher, Diana Velikonja, Amanda McIntyre, Shannon Janzen & Robyn Tate. (2014) INCOG Recommendations for Management of Cognition Following Traumatic Brain Injury, Part II. Journal of Head Trauma Rehabilitation 29:4, pages 321-337.
Crossref
Crossref
Rita Formisano & Nathan D. Zasler. (2014) Posttraumatic Parkinsonism. Journal of Head Trauma Rehabilitation 29:4, pages 387-390.
Crossref
Crossref
Ramon Diaz-ArrastiaPatrick M. KochanekPeter BergoldKimbra KenneyChristine E. MarxCol. Jamie B. GrimesLTC Yince LohLTC Gina E. AdamDevon OskvigKenneth C. CurleyCol. Wanda Salzer. (2014) Pharmacotherapy of Traumatic Brain Injury: State of the Science and the Road Forward: Report of the Department of Defense Neurotrauma Pharmacology Workgroup. Journal of Neurotrauma 31:2, pages 135-158.
Crossref
Crossref
Renato Anghinah, Fabio Rios Freire, Fernanda Coelho, Juliana Rhein Lacerda, Magali Taino Schmidt, Vanessa Tomé Gonçalves Calado, Jéssica Natuline Ianof, Sergio Machado, Bruna Velasques, Pedro Ribeiro, Luis Fernando Hindi Basile, Wellingson Silva Paiva & Robson Luis Amorim. (2013) BPSD following traumatic brain injury. Dementia & Neuropsychologia 7:3, pages 269-277.
Crossref
Crossref
Cara Camiolo Reddy, Michael Collins, Mark Lovell & Anthony P. Kontos. (2013) Efficacy of Amantadine Treatment on Symptoms and Neurocognitive Performance Among Adolescents Following Sports-Related Concussion. Journal of Head Trauma Rehabilitation 28:4, pages 260-265.
Crossref
Crossref
Heidi Blume & Karameh Hawash. (2012) Subacute concussion-related symptoms and postconcussion syndrome in pediatrics. Current Opinion in Pediatrics 24:6, pages 724-730.
Crossref
Crossref
Beth Slomine, Gianna Locascio & Megan Kramer. 2012. Executive Function and Dysfunction. Executive Function and Dysfunction
209
231
.
M. V. Chelyapina, E. V. Sharova & O. S. Zaitsev. (2012) Clinical and Electroencephalographic Effects of Amantadine Sulfate (PK-Merz) on the Background of Reduced Consciousness Due to Severe Brain Trauma. Neuroscience and Behavioral Physiology 42:8, pages 870-875.
Crossref
Crossref
Richard Ma, Chealon D. Miller, MaCalus V. Hogan, B. Kent Diduch, Eric W. Carson & Mark D. Miller. (2012) Sports-Related Concussion: Assessment and Management. Journal of Bone and Joint Surgery 94:17, pages 1618-1627.
Crossref
Crossref
Anthony L. Petraglia, Joseph C. Maroon & Julian E. Bailes. (2012) From the Field of Play to the Field of Combat. Neurosurgery 70:6, pages 1520-1533.
Crossref
Crossref
Joseph T. Giacino, John Whyte, Emilia Bagiella, Kathleen Kalmar, Nancy Childs, Allen Khademi, Bernd Eifert, David Long, Douglas I. Katz, Sooja Cho, Stuart A. Yablon, Marianne Luther, Flora M. Hammond, Annette Nordenbo, Paul Novak, Walt Mercer, Petra Maurer-Karattup & Mark Sherer. (2012) Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain Injury. New England Journal of Medicine 366:9, pages 819-826.
Crossref
Crossref
David Plantier, Jacques Luauté & Isabelle Richard. (2012) Prise en charge pharmacologique des troubles neurocomportementaux après traumatisme crânien : revue bibliographique, données pratiques actuelles. L'information psychiatrique 88:5, pages 375.
Crossref
Crossref
Anne Julie FrenetteSalmaan KanjiLaura ReesDavid R. WilliamsonMarc M. PerreaultAlexis F. TurgeonFrancis BernardDean A. Fergusson. (2012) Efficacy and Safety of Dopamine Agonists in Traumatic Brain Injury: A Systematic Review of Randomized Controlled Trials. Journal of Neurotrauma 29:1, pages 1-18.
Crossref
Crossref
Leanne Togher. 2012. Cognition and Acquired Language Disorders. Cognition and Acquired Language Disorders
326
345
.
Alexandra N. Garcia, Mansi A. Shah, C. Edward Dixon, Amy K. Wagner & Anthony E. Kline. (2011) Biologic and Plastic Effects of Experimental Traumatic Brain Injury Treatment Paradigms and Their Relevance to Clinical Rehabilitation. PM&R 3, pages S18-S27.
Crossref
Crossref
William P. MeehanIIIIII. (2011) Medical Therapies for Concussion. Clinics in Sports Medicine 30:1, pages 115-124.
Crossref
Crossref
Kathy Chuang, Nicole L. Stroud & Ross Zafonte. 2011. Youmans Neurological Surgery. Youmans Neurological Surgery
3516
3534
.
Mary Pat Murphy. 2011. Encyclopedia of Clinical Neuropsychology. Encyclopedia of Clinical Neuropsychology
2445
2447
.
Manoj SivanVera Neumann, Ruth Kent, Amanda Stroud & Bipinchandra B Bhakta. (2010) Pharmacotherapy for treatment of attention deficits after non-progressive acquired brain injury. A systematic review. Clinical Rehabilitation 24:2, pages 110-121.
Crossref
Crossref
Jilda N. Vargus-Adams, Mary A. McMahon, Linda J. Michaud, Judy Bean & Alexander A. Vinks. (2010) Pharmacokinetics of Amantadine in Children With Impaired Consciousness due to Acquired Brain Injury: Preliminary Findings Using a Sparse-sampling Technique. PM&R 2:1, pages 37-42.
Crossref
Crossref
Gail J. Pyne-Geithman, Danielle N. Caudell, Matthew Cooper, Joseph F. Clark & Lori A. Shutter. (2008) Dopamine D2-Receptor-Mediated Increase in Vascular and Endothelial NOS Activity Ameliorates Cerebral Vasospasm After Subarachnoid Hemorrhage In Vitro. Neurocritical Care 10:2, pages 225-231.
Crossref
Crossref
Joseph T. Giacino & Nicholas D. Schiff. 2009. The Neurology of Consciousness. The Neurology of Consciousness
173
190
.
Joan W. Mayfield, Linda Pedersen & Frank Mcdonald. 2009. Handbook of Clinical Child Neuropsychology. Handbook of Clinical Child Neuropsychology
745
763
.
Joachim Liepert. (2008) Pharmacotherapy in restorative neurology. Current Opinion in Neurology 21:6, pages 639-643.
Crossref
Crossref
Elizabeth Sawyer, Laurie S Maura & Martin J Ohlinger. (2008) Amantadine Enhancement of Arousal and Cognition After Traumatic Brain Injury. Annals of Pharmacotherapy 42:2, pages 247-252.
Crossref
Crossref
Joel Sadavoy, Krista L. Lanctôt & Shoumitro Deb. 2010. Cambridge Textbook of Effective Treatments in Psychiatry. Cambridge Textbook of Effective Treatments in Psychiatry
187
216
.
Anna M. Barrett & Paul J. Eslinger. (2007) Amantadine for Adynamic Speech. American Journal of Physical Medicine & Rehabilitation 86:8, pages 605-612.
Crossref
Crossref
Laurel J. Buxbaum, Mary Ferraro, John Whyte, Arthur Gershkoff & H Branch Coslett. (2007) Amantadine Treatment of Hemispatial Neglect. American Journal of Physical Medicine & Rehabilitation 86:7, pages 527-537.
Crossref
Crossref
Carolyn L Villareal. (2016) Amantadine Therapy in Traumatic Brain Injury Patients. Journal of Pharmacy Technology 23:2, pages 95-103.
Crossref
Crossref
Rob J Forsyth, Beena Jayamoni, Tom C Paine & Sandra Mascarenhas. (2006) Monoaminergic agonists for acute traumatic brain injury. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Simon Fleminger, Richard RJ Greenwood & Donna L Oliver. (2006) Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Peter D. Patrick, James A. Blackman, Jennifer L. Mabry, Marcia L. Buck, Matthew J. Gurka & Mark R. Conaway. (2016) Dopamine Agonist Therapy in Low-Response Children Following Traumatic Brain Injury. Journal of Child Neurology 21:10, pages 879-885.
Crossref
Crossref
Deborah L. WardenBarry GordonThomas W. McAllisterJonathan M. SilverJeffery T. BarthJohn BrunsAngela DrakeTony GentryAndy JagodaDouglas I. KatzJess KrausLawrence A. LabbateLaurie M. RyanMolly B. SparlingBeverly WaltersJohn WhyteAshley ZapataGeorge Zitnay. (2006) Guidelines for the Pharmacologic Treatment of Neurobehavioral Sequelae of Traumatic Brain Injury. Journal of Neurotrauma 23:10, pages 1468-1501.
Crossref
Crossref
Wayne A. Gordon, Ross Zafonte, Keith Cicerone, Joshua Cantor, Margaret Brown, Lisa Lombard, Rachel Goldsmith & Tina Chandna. (2006) Traumatic Brain Injury Rehabilitation. American Journal of Physical Medicine & Rehabilitation 85:4, pages 343-382.
Crossref
Crossref
Ingo KellerBritta HusemannKlaus ScheidtmannFerenc Tracik. (2006) Verlauf kognitiver Störungen nach Schädel-Hirn-Trauma unter Rivastigmin. Zeitschrift für Neuropsychologie 17:4, pages 257-267.
Crossref
Crossref
H. Leone & B. W. Polsonetti. (2005) Amantadine for traumatic brain injury: does it improve cognition and reduce agitation?. Journal of Clinical Pharmacy and Therapeutics 30:2, pages 101-104.
Crossref
Crossref
John Whyte, Douglas Katz, David Long, Madeline C. DiPasquale, Marcia Polansky, Kathleen Kalmar, Joseph Giacino, Nancy Childs, Walt Mercer, Paul Novak, Petra Maurer & Bernd Eifert. (2005) Predictors of outcome in prolonged posttraumatic disorders of consciousness and assessment of medication effects: A multicenter study. Archives of Physical Medicine and Rehabilitation 86:3, pages 453-462.
Crossref
Crossref
Ryan DeMarchi, Vikas Bansal, Anthony Hung, Karol Wroblewski, Hemi Dua, Sanjeev Sockalingam & Shree Bhalerao. (2014) Review of Awakening Agents. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 32:1, pages 4-17.
Crossref
Crossref
J.T. Giacino. 2005. The Boundaries of Consciousness: Neurobiology and Neuropathology. The Boundaries of Consciousness: Neurobiology and Neuropathology
381
395
.
C.-W. Wallesch. 2005. Frontalhirn. Frontalhirn
387
393
.
Liza B. Green, Joseph E. Hornyak & Edward A. Hurvitz. (2004) Amantadine in Pediatric Patients with Traumatic Brain Injury. American Journal of Physical Medicine & Rehabilitation 83:12, pages 893-897.
Crossref
Crossref
Joseph T. Giacino & Charlotte T. Trott. (2004) Rehabilitative Management of Patients With Disorders of Consciousness. Journal of Head Trauma Rehabilitation 19:3, pages 254-265.
Crossref
Crossref
John P. Phillips, Deidre J. Devier & Dennis M. Feeney. (2003) Rehabilitation Pharmacology. Journal of Head Trauma Rehabilitation 18:4, pages 342-356.
Crossref
Crossref
E Richer & L Tell. (2003) Indications, efficacité et tolérance des traitements médicamenteux susceptibles d’améliorer la reprise de conscience après un coma traumatique. Annales de Réadaptation et de Médecine Physique 46:4, pages 177-183.
Crossref
Crossref
RJ Forsyth, B Jayamoni & TC Paine. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
S Fleminger, RJ Greenwood & DL Oliver. 1996. The Cochrane Database of Systematic Reviews (Protocol). The Cochrane Database of Systematic Reviews (Protocol).
I Richard, B Perrouin-Verbe, J Rome, C Bernat & J.F Mathé. (2003) Traitement pharmacologique des troubles du comportement post-traumatiques. Annales de Réadaptation et de Médecine Physique 46:1, pages 49-57.
Crossref
Crossref
Jay M. Meythaler, Robert C. Brunner, Alice Johnson & Thomas A. Novack. (2002) Amantadine to Improve Neurorecovery in Traumatic Brain Injury–Associated Diffuse Axonal Injury. Journal of Head Trauma Rehabilitation 17:4, pages 300-313.
Crossref
Crossref
M.L.C. Labi. (2002) Tratamiento neurofarmacológico tras un traumatismo craneoencefálico. Rehabilitación 36:6, pages 364-372.
Crossref
Crossref
C.-W. Wallesch. 2002. Frontalhirn. Frontalhirn
327
335
.
Robert J. Hamm. (2001) Neurobehavioral Assessment of Outcome following Traumatic Brain Injury in Rats: An Evaluation of Selected Measures. Journal of Neurotrauma 18:11, pages 1207-1216.
Crossref
Crossref
Ross D. Zafonte, Jan Lexell & Nora Cullen. (2001) Possible Applications for Dopaminergic Agents Following Traumatic Brain Injury: Part 2. Journal of Head Trauma Rehabilitation 16:1, pages 112-116.
Crossref
Crossref